October 10, 2017 — Infinitt announced that its DoseM web-based radiation dose management system will now include an ...
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company's magnetic resonance/radiation therapy (MR/RT) system at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego.
October 10, 2017 — Carestream will be highlighting several of its imaging systems and healthcare information technology ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
October 9, 2017 — A clinical trial conducted at Stanford University Medical Center published online in Anesthesia & ...
October 9, 2017 — Medis has released a new version of its QAngio CT (computed tomography), which can now be launched ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
As the healthcare industry transforms from volume to value, and from a system dependent upon machines to a system ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
How does a radiologist become a Patient-Centered practitioner? Here, Everything Rad explores this timely question. This post, number two in a 3-part series, covers the true definition of this model of care, the crucial role of empathy, and delivers specific strategies for achieving a Patient-Centered radiology practice.
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains how ...
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key ...
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
October 5, 2017 — Infinitt North America announced it will highlight several healthcare information technology (IT) ...
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx) System for the treatment of nonmelanoma skin cancer (NMSC) and early-stage breast cancer during the 2017 American Society for Radiation Oncology (ASTRO) meeting, Sept. 24-27 in San Diego. iCAD also hosted additional presentations and a series of peer-to-peer discussion opportunities with leading eBx experts at its booth.
MedLever demonstrated its flagship platform and applications that simplify clinical workflow, enable interoperability, and enhance clinical and scientific research at the 2017 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego.
Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...
October 5, 2017 — CompleWare and Vida recently announced a joint marketing agreement promoting complementary respiratory ...
October 5, 2017 — To provide lifesaving surgical care for sick children in one of the most underserved countries, 13 ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational clinical trial evaluating the impact of fluciclovine (18F) PET/CT imaging on clinical management of men with biochemically recurrent prostate cancer eligible for salvage therapy.
HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast health diagnostic services more accessible and convenient across the greater Houston region. The collaboration will result in 16 local sites by the end of 2018, including the Oct. 2 grand opening of a new dedicated breast health center at HCA-affiliated The Woman’s Hospital of Texas.
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) each than following two, 9-Gy fractions of high-dose-rate (HDR) brachytherapy, but neither overall survival nor severe treatment-related side effects differed between the treatment groups.
October 4, 2017 — Kubtec announced at the annual conference of the American Association of Pathology Assistants (AAPA) ...
In the 1980s I was enthralled with hybridomas. Created by fusing human tumor cells with cells from mouse spleens that ...
According to a new Market Study Report,1 the automated breast ultrasound system (ABUS) market will see a 21 percent compound annual growth rate (CAGR) from 2017-2024, driven by rising incidence of breast cancer and volume scanner segment dominating this growth.